869 related articles for article (PubMed ID: 24119238)
1. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
Van Rheenen TE; Rossell SL
Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
[TBL] [Abstract][Full Text] [Related]
2. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).
Yatham LN; Torres IJ; Malhi GS; Frangou S; Glahn DC; Bearden CE; Burdick KE; Martínez-Arán A; Dittmann S; Goldberg JF; Ozerdem A; Aydemir O; Chengappa KN
Bipolar Disord; 2010 Jun; 12(4):351-63. PubMed ID: 20636632
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
[TBL] [Abstract][Full Text] [Related]
4. Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery.
Sperry SH; O'Connor LK; Öngür D; Cohen BM; Keshavan MS; Lewandowski KE
J Int Neuropsychol Soc; 2015 Jul; 21(6):468-72. PubMed ID: 26154947
[TBL] [Abstract][Full Text] [Related]
5. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
7. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive profile of euthymic Japanese patients with bipolar disorder.
Ishisaka N; Shimano S; Miura T; Motomura K; Horii M; Imanaga H; Kishimoto J; Kaneda Y; Sora I; Kanba S
Psychiatry Clin Neurosci; 2017 Jun; 71(6):373-382. PubMed ID: 28025861
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive functioning in patients recently diagnosed with bipolar disorder.
Hellvin T; Sundet K; Simonsen C; Aminoff SR; Lagerberg TV; Andreassen OA; Melle I
Bipolar Disord; 2012 May; 14(3):227-38. PubMed ID: 22548896
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
[TBL] [Abstract][Full Text] [Related]
11. A comparison of euthymic bipolar patients with unaffected first-degree relatives and healthy controls in terms of neuropsychological functions.
Civil Arslan F; Tiryaki A; Ozkorumak E
Int J Psychiatry Clin Pract; 2014 Aug; 18(3):208-14. PubMed ID: 24164495
[TBL] [Abstract][Full Text] [Related]
12. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
[TBL] [Abstract][Full Text] [Related]
13. Autonomic nervous system arousal and cognitive functioning in bipolar disorder.
Levy B
Bipolar Disord; 2013 Feb; 15(1):70-9. PubMed ID: 23237079
[TBL] [Abstract][Full Text] [Related]
14. Executive deficits: a continuum schizophrenia-bipolar disorder or specific to schizophrenia?
Ancín I; Cabranes JA; Santos JL; Sánchez-Morla E; Barabash A
J Psychiatr Res; 2013 Nov; 47(11):1564-71. PubMed ID: 23907000
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
[TBL] [Abstract][Full Text] [Related]
16. Cognitive functioning in euthymic bipolar I and bipolar II patients.
Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression.
Kessler U; Schoeyen HK; Andreassen OA; Eide GE; Hammar Å; Malt UF; Oedegaard KJ; Morken G; Sundet K; Vaaler AE
BMC Psychiatry; 2013 Apr; 13():105. PubMed ID: 23557429
[TBL] [Abstract][Full Text] [Related]
18. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
20. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.
Burton CZ; Vella L; Harvey PD; Patterson TL; Heaton RK; Twamley EW
Schizophr Res; 2013 May; 146(1-3):244-8. PubMed ID: 23507359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
